EU approves Kisunla drug for Alzheimer and #39;s with reservations

Last week, the European Union authorized the marketing of Kisunla, a drug produced by the American company Eli Lilly, for the treatment of mild cognitive impairment and early dementia caused by Alzheimer and #39;s disease.

Informatie preluata din publicatia "Bursa" - citeste integral articolul - click aici